Do you want to read an article? Please log in or register.
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study
Cardiovascular Risk and Diseases
RECOMMENDED
Related content
Heart, Artery and Coronary Diseases
A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia-Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Diabetes Care
Yoshida Y, Nguyen NQ, Moon EH, Rebholz C, Skali H, Arthur V, Echouffo-Tcheugui JB, Ballantyne C, Selvin E, Shah A, Kaplan R, Rodriguez CJ, Qi Q, Cheng S, Yu B
doi: 10.2337/dc25-0730
RECOMMENDED
Heart Failure
Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi-Ethnic Study of Atherosclerosis: The Pooling Project
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Heart Assoc
Nomura S, Guan W, Zhang Y, Tison GH, Ikezaki H, Diffenderfer MR, Liu CT, Hoogeveen RC, Ballantyne CM, Schaefer EJ, Tsai MY
doi: 10.1161/JAHA.124.038608
COMMENTED
Cardiovascular Risk and Diseases
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL
doi: 10.1016/S2213-8587(25)00295-5
Cardiovascular Risk and Diseases
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies
Ann Intern Med
Saeed A, Mulukutla SR, Thoma F, Lemon L, Koczo A, Reis S, Marroquin O, Kip K
doi: 10.7326/ANNALS-24-00775
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional study
Atherosclerosis
Cederström S, Wang Y, Lundman P, Alfredsson J, Bergström G, Engström G, Lind L, Söderberg S, Tornvall P, Jernberg T
doi: 10.1016/j.atherosclerosis.2025.120457
Heart, Artery and Coronary Diseases
Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study
Atherosclerosis
Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM
doi: 10.1016/j.atherosclerosis.2025.120390
COMMENTED
Cardiovascular Risk and Diseases
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB, SOUL Study Group
doi: 10.1056/NEJMoa2501006
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study
Atherosclerosis
Conte E, Lee SE, Chang HJ, Hadamitzky M, Kim YJ, Pontone G, Budoff MJ, Gottlieb I, Lee BK, Chun EJ, Cademartiri F, Maffei E, Marques H, Di Lenarda F, Guarnieri G, Leipsic JA, Shin S, Choi JH, Mouaz AM, Chinnaiyan K, Pedro AG, Sung JM, Virmani R, Samady H, Lin FY, Stone PH, Narula J, Shaw L, Bax JJ, Andreini D
doi: 10.1016/j.atherosclerosis.2025.119184
Cardiovascular Risk and Diseases
Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study
J Am Heart Assoc
Wald RM, Tomlinson G, Caldarone CA, Dahdah N, Dallaire F, Drolet C, Farkouh ME, Grewal J, Hancock-Friesen C, Hickey EJ, Karur GR, Keir M, Kovacs AH, Leonardi B, McCrindle BW, Nadeem SN, Ng MY, Samuel M, Shah A, Tham EB, Therrien J, Van De Bruaene A, Vonder Muhll IF, Warren AE, Yamamura K, Khairy P
doi: 10.1161/JAHA.124.039006